- Report
- March 2026
- 47 Pages
Thailand
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Switzerland
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Sweden
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Spain
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
South Korea
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Singapore
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Russia
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Netherlands
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Japan
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Italy
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
China
From €1207EUR$1,350USD£1,043GBP
- Report
- March 2026
- 70 Pages
Brazil
From €1207EUR$1,350USD£1,043GBP
- Report
- January 2025
- 132 Pages
Global
From €849EUR$950USD£734GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more
